Navigation Links
eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results
Date:2/26/2008

stomers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements, including, but not limited to, 2008 financial guidance, involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

eResearchTechnology, Inc. and Subsidiaries

Consolidated Statements of Operations

(in thousands, except per share amounts)

Three Months Ended December 31, The Year Ended December 31,

2006 2007 2006 2007

(unaudited) (unaudited) (unaudited)

Net revenues:

Licenses $681 $687 $3,017 $2,700

Services 13,269 21,565 55,309 69,547

Site support 5,975 6,657 28,042 26,451

Total net revenues 19,925 28,909 86,368 98,698

Costs of revenues:

Cost of licenses 58
'/>"/>

SOURCE eResearchTechnology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
2. eResearchTechnology to Present at the UBS Global Healthcare Services Conference 2008 on February 11th
3. eResearchTechnology, Inc. to Announce 2007 Fourth Quarter Results on February 26, 2008
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. QMed, Inc. Reports July Medicare SNP Enrollments
6. Phlo Affiliate Reports Expanded Coverage to Oregon Border
7. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
8. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
9. Carrington Reports Second Quarter 2007 Results
10. Avitar Reports Third Quarter Financial Results for Fiscal 2007
11. Response Genetics Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... Manhattan, KS (PRWEB) , ... June 29, 2015 ... ... US PATENT 7736892 B2. Under the terms of the agreement, MediVet will acquire ... Matrix Stem Cells (UCMSCs). MB-007 is currently in pre-clinical development as a potential ...
(Date:6/29/2015)... 29, 2015  Neuralstem, Inc. (NYSE MKT: CUR), a ... small molecule and cell therapy treatments for central nervous ... for listing on the NASDAQ Capital Market under the ... trade on the NYSE MKT until the market close ... Market is expected to commence on July 13, 2015. ...
(Date:6/29/2015)... , June 29, 2015 ... medical information products and services, today announced the highlights ... to the 2014 Journal Citation Reports® (JCR) published by ... Factors increase from 2013 to 2014, ahead of the ... the top rank in 62 subject categories, up from ...
(Date:6/26/2015)... 2015  A San Francisco company, Pembient, recently announced ... rhino horn: beer in China ... In response to the emerging industry, two leading rhino ... of synthetic rhino horn.  The ... Rhino International (SRI) released a joint statement ...
Breaking Biology Technology:MediVet Biologics Acquires Exclusive Patent License from Kansas State University 2MediVet Biologics Acquires Exclusive Patent License from Kansas State University 3Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 2Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 3Elsevier Announces 2014 Citation Impact Highlights 2Elsevier Announces 2014 Citation Impact Highlights 3Rhino Experts Oppose Synthetic Rhino Horn as Solution to Poaching Crisis 2
... Neurocrine Biosciences, Inc.,(Nasdaq: NBIX ) announced ... Neurocrine Biosciences will be presenting at the 20th,Annual Piper ... The live "fireside chat" ... Eastern Time (ET) /10:30 a.m. Pacific Time (PT). The,presentation ...
... MINRAD International, Inc. (Amex: BUF ), announced effective ... 50 positions. , , ... taken this difficult, but necessary action to reduce our cost ... adverse financial condition as we discussed in our recently announced ...
... BMP Sunstone,Corporation (Nasdaq: BJGP ) ("BMP ... subsidiary, Sunstone (Tangshan) Pharmaceutical Co., Ltd,("Sunstone"), has signed ... hard capsule (LFHC) used to treat constipation. ... sealing production line, as well as,related LFHC technology ...
Cached Biology Technology:MINRAD International, Inc. Announces Reduction in Workforce 2BMP Sunstone Acquires 'Runchang Capsule' and Related LFHC Technology 2BMP Sunstone Acquires 'Runchang Capsule' and Related LFHC Technology 3
(Date:6/24/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced that Sharp has selected its industry-leading Natural ... its latest flagship smartphone device, the AQUOS ZETA ... shipments of its fingerprint ID sensor technology, this ... and leadership in the biometrics market through its ...
(Date:6/23/2015)... June 23, 2015   Valencell, a ... results of a recent study that illustrates its ... wrist during activity. In a study conducted at ... along with the Apple Watch against a chest ... rate during activity. The study demonstrated that Valencell,s ...
(Date:6/17/2015)... HILDEN, Germany , June 17, 2015 /PRNewswire/ ... Prime Standard: QIA) today launched new Investigator ® STR ... in the United States . The new ... multiple key genomic markers (short tandem repeats or STRs) for ... to evaluate the quality of DNA in each sample, a ...
Breaking Biology News(10 mins):Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5
... of those diseases few have heard of unless you know ... child or teenager -- it is devastating. Symptoms are mild ... impairment and slurred speech, but eventually the symptoms progress and ... in life. There is no cure at this time, but ...
... a person's under stress or injured, the adrenal gland ... normal. But the hormone's effects are many and varied, ... memories with short-term exposure, while impairing learning if there's ... its effects,understanding how cortisol is made is essential to ...
... know how to digest cellulose, but the human process ... The central bottleneck is the sluggish rate at which ... into sugars, which are then fermented into ethanol. , ... scientists has conducted molecular simulations at the San Diego ...
Cached Biology News:Moonlighting enzyme linked to neurodegenerative disease 2Moonlighting enzyme linked to neurodegenerative disease 3Scientists unravel clue in cortisol production 2Meeting the ethanol challenge: Scientists use supercomputer to target cellulose bottleneck 2Meeting the ethanol challenge: Scientists use supercomputer to target cellulose bottleneck 3
Anti-Wnt-2 Polyclonal Antibody Description: 100 g purified goat polyclonal antibody. Reacts with human/mouse/rat. Tested in Western blot/IP/IHC. Research Focus: signal transduction Storage...
... calibration, and validation (MCV) plate ... plate used for hands-free startup, ... using the Bio-Plex suspension array ... for use with Bio-Plex Manager ...
... first biological reagent that eliminates ... not just by inhibiting growth. ... agent that can be used ... The cytotoxicity of Mynox is ...
A component of the Acridinium protein labeling kit....
Biology Products: